Acumen Pharmaceuticals, Inc. Annual Nonoperating Income (Expense) in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Acumen Pharmaceuticals, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2020 to 2023.
  • Acumen Pharmaceuticals, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $2.5M, a 18.9% decline year-over-year.
  • Acumen Pharmaceuticals, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $11.2M, a 37.7% increase year-over-year.
  • Acumen Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2023 was $8.77M, a 268% increase from 2022.
  • Acumen Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2022 was $2.38M.
  • Acumen Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2021 was -$81M, a 13903% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $8.77M +$6.39M +268% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-26
2022 $2.38M +$83.4M Jan 1, 2022 Dec 31, 2022 10-K 2024-03-26
2021 -$81M -$81.6M -13903% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-27
2020 $587K Jan 1, 2020 Dec 31, 2020 10-K 2022-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.